The UK needs new regulations for AI products used in the NHS and other healthcare settings, according to the country’s medical device regulator.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has published 44 recommendations to update its policies as AI use in healthcare increases. The report was compiled by an independent commission involving input from more than 12,000 people, including patients and clinicians.
Key Recommendations
The recommendations include:
- Continuous monitoring of AI products, with removal from regulatory approval if they malfunction or become less effective over time
- Giving patients the right to know whether AI is involved in their care
- The power to penalize AI developers if products fail to meet required standards
- An AI “L plate” system allowing new models to be trialled by healthcare professionals under close supervision
MHRA chief Lawrence Tallon told the BBC that AI will soon be routinely used within the NHS. “What I would expect is that patients will… increasingly see AI as part of the way that normal NHS healthcare is delivered,” he said. “That should happen in a way that they can maintain their trust and their confidence in what’s happening”.
Laat een reactie achter